Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
No dosing errors
Researchers may study these peptides together to compare how distinct signaling pathways behave in a multi-compound experimental model
2286-C CircZBTB46 ALLEVIATES NON-ALCOHOLIC FATTY LIVER DISEASE BY TARGETING MIR-326/FGF1/AMPK AXIS Qingmin Zeng 1 , Chang-Hai Liu 1 , Wei Jiang 1 , Dongbo Wu 1 and Hong Tang 2 , (1)West China Hospital, Sichuan University, (2)West China Hospital of Sichuan University Background: Non-alcoholic fatty liver disease (NAFLD) is currently the most prevalent cause of chronic liver diseases worldwide
Osmotics Cosmeceuticals Blue Copper 5 Firming Elasticity Repair Cream
A pilot study suggested that plasma exchange with human serum albumin 5% (PEA5%) as a replacement fluid is feasible and safe in patients with ACLF and may improve organ function and survival
US$ 20.66
US$ 23.80
US$ 24.55
US$ 26.48
US$ 21.26
US$ 27.01
